Tumor suppressor and immediate early transcription factor genes in non-small cell lung cancer.
Non-small lung cancer (NSCLC) is a disease that exhibits multiple genetic lesions. Lung Cancer Study Group (LCSG) 871 was designed to analyze this group of malignancies for alterations in growth factors and/or their receptors, oncogenes, tumor suppressor genes, and immediate early transcription factor genes. Immunohistochemical analysis showed that 32% of evaluable cases studied contained absent or abnormal Rb expression. Sequence analysis of the p53 gene revealed that 58% of these cancers contained structural alterations of this gene, whereas only 45% of these cases overexpressed p53 by immunohistochemical analysis. Finally, both Northern blot and immunohistochemical analysis showed that these tumors exhibited changes in the mRNA and protein expression levels respectively of the immediate early transcription factor genes c-fos, c-jun, and EGR, in that less expression of these genes was evident in the tumors compared with adjacent normal tissue. Understanding both the biologic and molecular significance of these findings may allow us to explore novel modalities for treatment of this disease.
Levin
W J
WJ
Department of Medicine, UCLA School of Medicine.
Casey
G
G
Ramos
J C
JC
Arboleda
M J
MJ
Reissmann
P T
PT
Slamon
D J
DJ
D002289:Carcinoma, Non-Small-Cell Lung / Q000235:genetics*; D002986:Clinical Trials as Topic; D015870:Gene Expression; D016147:Genes, Tumor Suppressor; D016762:Genes, fos / Q000235:genetics; D016758:Genes, jun / Q000235:genetics; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000235:genetics*; D015337:Multicenter Studies as Topic; D009154:Mutation; D015347:RNA Probes; D016032:Randomized Controlled Trials as Topic; D017422:Sequence Analysis, DNA; D014158:Transcription, Genetic
D015347:RNA Probes